FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ivor Caro

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Craig L Leonardi; Alan Menter; T Hamilton; Ivor Caro; B Xing; Alice B Gottlieb
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis.
Vera H Price; Maria Hordinsky; Elise A Olsen; Janet L Roberts; Elaine Siegfried; Elyse S Rafal; Neil J Korman; Basel Altrabulsi; Hoi M Leung; Marvin Garovoy; Ivor Caro; David A Whiting
Subcutaneous efalizumab is not effective in the treatment of alopecia areata.
Kim A Papp; Ivor Caro; Hoi M Leung; Marvin Garovoy; Philip J Mease
Efalizumab for the treatment of psoriatic arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ivor Caro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Craig L Leonardi; Alan Menter; T Hamilton; Ivor Caro; B Xing; Alice B Gottlieb
Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis.
The British journal of dermatology 2008;158(5):1107-16.
2008: Vera H Price; Maria Hordinsky; Elise A Olsen; Janet L Roberts; Elaine Siegfried; Elyse S Rafal; Neil J Korman; Basel Altrabulsi; Hoi M Leung; Marvin Garovoy; Ivor Caro; David A Whiting
Subcutaneous efalizumab is not effective in the treatment of alopecia areata.
Journal of the American Academy of Dermatology 2008;58(3):395-402.
2007: Kim A Papp; Ivor Caro; Hoi M Leung; Marvin Garovoy; Philip J Mease
Efalizumab for the treatment of psoriatic arthritis.
Journal of cutaneous medicine and surgery 2007;11(2):57-66.
2006: Kim A Papp; Reni Bressinck; Scott Fretzin; Bernard S Goffe; Steven Kempers; Kenneth B Gordon; Ivor Caro; Patricia A Walicke; Xiaolin Wang; Alan Menter
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial.
International journal of dermatology 2006;45(5):605-14.
2006: Kim A Papp; Bruce Miller; Kenneth B Gordon; Ivor Caro; Paul Kwon; Peter G Compton; Craig L Leonardi
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
Journal of the American Academy of Dermatology 2006;54(4 Suppl 1):S164-70.
2006: Alice B Gottlieb; Tiffani Hamilton; Ivor Caro; Paul Kwon; Peter G Compton; Craig L Leonardi
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
Journal of the American Academy of Dermatology 2006;54(4 Suppl 1):S154-63.
2005: Kim A Papp; Charles Camisa; Stephen P Stone; Ivor Caro; Xiaolin Wang; Peter G Compton; Patricia A Walicke; Alice B Gottlieb
Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part II.
Journal of cutaneous medicine and surgery 2005;9(6):313-23.
2005: Richard G B Langley; Wayne P Carey; Elyse S Rafal; Stephen K Tyring; Ivor Caro; Xiaolin Wang; Graham Wetherill; Kenneth B Gordon
Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience.
Clinical therapeutics 2005;27(9):1317-28.
2005: Craig L Leonardi; Kim A Papp; Kenneth B Gordon; Alan Menter; Steven R Feldman; Ivor Caro; Patricia A Walicke; Peter G Compton; Alice B Gottlieb
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Journal of the American Academy of Dermatology 2005;52(3 Pt 1):425-33.
2005: Alan Menter; Kenneth Gordon; Wayne Carey; Tiffani Hamilton; Scott Glazer; Ivor Caro; Nicole Li; Wayne Gulliver
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
Archives of dermatology 2005;141(1):31-8.
2004: Alice B Gottlieb; Kenneth B Gordon; Mark Lebwohl; Ivor Caro; Patricia A Walicke; Nicole Li; Craig L Leonardi
Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.
Journal of drugs in dermatology : JDD 2004;3(6):614-24.
2004: Denis Jullien; J C Prinz; Richard G B Langley; Ivor Caro; W Dummer; A Joshi; R Dedrick; P Natta
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.
Dermatology (Basel, Switzerland) 2004;208(4):297-306.
2003: Nick J Lowe; John Gonzalez; Jerry Bagel; Ivor Caro; Charles Ellis; Alan Menter
Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy.
International journal of dermatology 2003;42(3):224-30.